GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of switched from compounded to brand and the titration reset itself — 19 comments in the full submission. View in context.
127
c/compounding·submitted 21 days ago by u/receptor_bias_rick

switched from compounded to brand and the titration reset itself

Pricingbranch of 8 comments

Long-ish post, sorry. tl;dr at the bottom. I have been tracking 503A against ApoB for 15 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one assay, no…

Read the full submission and all 19 comments →

This branch

8 comments, started 21 days ago
u/marit_laurent16 points·21 days ago

Every time this gets posted it hits the front page and every time someone has to re-explain it.

replysharereportpermalink
u/lift_heavy_thingsresistance training23 points·20 days ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/receptor_bias_rickOP0 points·20 days ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink
u/kavya_kravchenko1 point·19 days ago·edited

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
[removed]1 point·19 days ago

[removed by moderator]

replysharereportpermalink
u/santiago_rasmussen8 points·20 days ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/julia_erdogan9 points·20 days ago

API source questions are on-topic and compounders dodging them is newsworthy

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →